A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide-Reference-Cited by-同舟云学术

A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide

Published:2024-08-24 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Coulomb Denis¹,Szablewski Vanessa²,Robert Nicolas³,Dupuy Anne-Marie⁴,Berrahouane Rayane¹,Goulabchand Radjiv⁵,Moreaux Jérôme³⁶⁷,Maria Alexandre Thibault Jacques⁸⁹,Herbaux Charles¹⁶

Affiliation:

1. Department of Clinical Hematology, CHU de Montpellier , Montpellier, France

2. Department of Pathology, CHU de Montpellier , Montpellier, France

3. Department of Biological Hematology, CHU de Montpellier , Montpellier, France

4. Department of Biochemistry, CHU de Montpellier , Montpellier, France

5. Desbrest Institute of Epidemiology and Public Health, University of Montpellier and INSERM , Montpellier, France

6. UMR CNRS-UM 9002, Institute of Human Genetics , Montpellier, France

7. Institut Universitaire de France (IUF) , Paris, France

8. Department of Internal Medicine & Onco-Immunology (MedI2O), CHU de Montpellier , Montpellier, France

9. Institute for Regenerative Medicine and Biotherapy (IRMB), University of Montpellier , Montpellier, France

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keae448/59018826/keae448.pdf

Reference7 articles.

1. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease;Wallace;Arthritis Rheumatol,2020

2. Advances in the diagnosis and management of IgG4 related disease;Lanzillotta;BMJ,2020

3. Therapeutic uses of rituximab and clinical features in immunoglobulin G4-related disease: a systematic review;Patel;Cureus,2023

4. Clinical perspectives on IgG4-related disease and its classification;Katz;Annu Rev Med,2022

5. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis;Omar;Rheumatology,2020